Hyeon-Jeong Hwang

Ms. Hyeon-Jeong Hwang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HHHyeon-Jeong Hwang
Hyeon-Jeong Hwang
YNYoungsang Nam
Youngsang Nam
CJChanhee Jang
Chanhee Jang
EKEun La Kim
Eun La Kim
EJEun Seo Jang
Eun Seo Jang
SLSeoung Rak Lee
Seoung Rak Lee
Cancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent biological activity. This review identifies and discusses cytotoxic RiPPs across various plant families, focusing on their absolute chemical structures and reported cytotoxic activities against cancer cell lines. Notably, plant-derived RiPPs such as rubipodanin A and mallotumides A–C demonstrated low nanomolar IC50 values against multiple cancer cell types, highlighting their therapeutic potential. By integrating traditional ethnobotanical knowledge with modern genomic and bioinformatic approaches, this study underscores the importance of plant RiPPs as a resource for developing innovative cancer treatments. These findings pave the way for further exploration of plant RiPPs, emphasizing their role in addressing the ongoing challenges in oncology and enhancing the repertoire of effective anticancer therapies.

30 June 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
HHHyeon-Jeong Hwang
Hyeon-Jeong Hwang
HLHyeokjin LIM
Hyeokjin LIM
Jae Sik YuJae Sik Yu
Jae Sik Yu
EJEun Seo Jang
Eun Seo Jang
YNYoungsang Nam
Youngsang Nam
SLSeoung Rak Lee
Seoung Rak Lee
Marine organism-associated microbes are an important source of structurally diverse and biologically active secondary metabolites exhibiting antimicrobial, anticancer, and anti-inflammatory activities. In this study, we investigated Penicillium brevicompactum MSW10-1, isolated from Hydractinia echinata, a marine invertebrate adapted to extreme intertidal and subtidal environments with variable temperature, salinity, and oxygen conditions. Through a combination of LC/MS-guided chemical analysis and chromatographic purification, eight secondary metabolites were isolated, including brevicolactones A (1) and B (2). The absolute chemical structures of 1 and 2 were determined based on NMR spectroscopic experiments, HR-ESIMS data, and quantum chemical ECD calculations. The isolated compounds (1–8) were evaluated for their ability to inhibit hepatic lipogenesis, a key process in lipid metabolism that is dysregulated in metabolic-dysfunction-associated steatotic liver disease. Furthermore, the inhibitory effects of the isolated compounds on lipid accumulation were further evaluated in primary mouse hepatocytes, using Oil Red O staining. These findings suggested that the isolated compounds may serve as promising candidates for the treatment of metabolic liver diseases associated with lipid dysregulation.

Verified
Journal Article
Open access
PDF file
TKTae Gyun Kim
Tae Gyun Kim
CHChaeyun Hong
Chaeyun Hong
YNYoungsang Nam
Youngsang Nam
EJEun Seo Jang
Eun Seo Jang
YLYeo Jin Lee
Yeo Jin Lee
SLSeoung Rak Lee
Seoung Rak Lee
Marine microorganisms, particularly members of the marine Roseobacter-group, participate in chemically mediated associations with phytoplankton, macroalgae, and marine invertebrates. This review examines structurally characterized, host-associated metabolites produced by Roseobacter-group bacteria within this ecological framework. These metabolites include sulfur-containing compounds, nitrogen-containing and hybrid scaffolds, pigments, lipids, and signaling molecules, exemplified by the antibacterial tropodithietic acid and the algaecidal roseobacticides. We discuss biosynthetic connections between phenylacetate and sulfur metabolism that give rise to tropodithietic acid and roseobacticides, as well as tryptophan–sinapic-acid-derived hybrid pathways. By integrating genomic potential, host-derived elicitors, metabolomics, structure elucidation, and experimentally demonstrated activities, this review distinguishes chemically characterized products from bioinformatically predicted pathways and proposed applications.